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A number of substances based on the 1,2-diarylethylamine template have been 
investigated for various potential clinical applications whereas others have been 
encountered as research chemicals sold for non-medical use. Some of these 
substances have transpired to function as NMDA receptor antagonists that elicit 
dissociative effects in people who use these substances recreationally. 1-[1-(2-
Fluorophenyl)-2-phenylethyl]pyrrolidine (fluorolintane, 2-F-DPPy) has recently 
appeared as a research chemical, which users report has dissociative effects. One 
common difficulty encountered by stakeholders confronting the appearance of new 
psychoactive substances is the presence of positional isomers. In the case of 
fluorolintane, the presence of the fluorine substituent on either the phenyl and benzyl 
moieties of the 1,2-diarylethylamine structure results in a total number of six possible 
racemic isomers, namely 2-F-, 3-F-, and 4-F-DPPy (phenyl ring substituents) and 2’’-
F-, 3’’-F-, and 4’’-F-DPPy (benzyl ring substituents). The present study reports the 
chemical syntheses and comprehensive analytical characterizations of the two sets 
of three positional isomers. These studies included various low- and high-resolution 
mass spectrometry platforms, gas- and liquid chromatography (GC and LC), nuclear 
magnetic resonance spectroscopy (NMR) and GC-condensed phase and attenuated 
total reflection infrared spectroscopy analyses. The differentiation between each set 
of three isomers was possible under a variety of experimental conditions including 
GC chemical ionization triple quadrupole tandem mass spectrometric analysis of the 
[M + H – HF]+ species. The latter MS method was particularly helpful as it revealed 




The 1,2-diarylethylamine template gives rise to a range of substances that have been 
evaluated for various properties including neuroprotective, anticonvulsant, analgesic, 
bronchodilator and sympathomimetic effects.1-3 More recent examples include 
remacemide and lanicemine that have undergone clinical investigations in areas 
linked to depression, seizure, stroke, and neurodegenerative disorders.4,5 At the 
same time, a number of 1,2-diphenylethylamines, including diphenidine and 
methoxyphenidine, have attracted attention due to their appearance and 
classification as new psychoactive substances (NPS) and reports of non-medical 
use.6 A common pharmacological feature shared between many 1,2-
diarylethylamines and related arylcyclohexylamines including phencyclidine (PCP) 
and ketamine (Figure 1) is NMDA receptor blockage and dissociative effects in 
humans.6-8 1-[1-(2-Fluorophenyl)-2-phenylethyl]pyrrolidine (fluorolintane, 2-FPPP, 2-
F-DPPy) (Figure 1) has appeared as a research chemical and is reported to display 
dissociative properties in users7 though its pharmacological and analytical properties 
have not yet been extensively characterized. Fluorolintane is also the fluorinated 
derivative of 1-(1,2-diphenylethyl)pyrrolidine or DPPy, which has been investigated 
as an NMDAR antagonist for possible neuroprotective activities.9 The nomenclature 
DPPy for 1-(1,2-diphenylethyl)pyrrolidine was chosen to be consistent with the 
arylcycloalkylamine nomenclature used given the overlapping benzylamine 
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pharmacophore of these two series. Thus the first two letters (DP) refer to the 
diphenyl rings and the last two letters (Py) refers to the pyrrolidine ring. Similarly 
diphenidine is abbreviated DPP.7  
Following on from previous work on the analytical and pharmacological 
characterization of dissociative substances,10-15 it was considered necessary to 
extend the explorations to emerging NPS of this type. Some basic analytical data for 
fluorolintane are available in the public domain16 and a synthetic route  has recently 
been described.17 The enantioselective preparations of 2’’-F-DPPy and 4’’-F-DPPy 
(Figure 1) by hydrogenation of the enamine precursor have also been reported.18,19 
However, more extensive characterizations are currently unavailable. Whilst 
fluorolintane is available commercially from chemical suppliers, a frequent challenge 
in the detection of emerging NPS includes the differentiation between positional 
isomers. In the case of fluorolintane (2-F-DPPy), the fluorine substituent is located at 
the 2-position of the phenyl ring, which means that five additional racemic isomers 
are possible if one considers the potential presence of the fluorine substituent at the 
phenyl or benzyl moiety, thus leading to six possible racemic isomers (Figure 1). The 
present study reports on the syntheses of these racemates followed by 
comprehensive analytical characterizations using various mass spectrometry (MS) 
platforms, gas- and liquid chromatography (GC and LC), nuclear magnetic 
resonance spectroscopy (NMR) and infrared (IR) analysis. It is aimed to make these 
analytical data available to those stakeholders who are confronted with newly 
emerging psychoactive substances. Pharmacological studies carried out by the 
authors revealed the substances’ interaction with the N-methyl-D-aspartate (NMDA) 
receptor and other biological targets including monoamine transporters that will be 




2.1 Reagents and standards 
 
All chemicals used for syntheses were obtained from Sigma Aldrich (St Louis, MO, 
USA). Column chromatography was performed using Merck silica gel grade 9385 
(230-400 mesh, 60 Å). Melting points were determined using a Digimelt A160 SRS 
digital melting point apparatus (Stanford Research Systems, Sunnyvale, CA, USA) at 
a ramp rate of 2 °C/min.  
2.2 Syntheses 
 
Preparation of 1-(1,2-diphenylethyl)pyrrolidine) (DPPy)  
A suspension of benzyl bromide (1.12 mL, 9.42 mmol), zinc dust (<10 µm, 0.616 g, 
9.42 mmol) and trifluroacetic acid (90 µL, 1.18 mmol) in 40 mL of dry tetrahydrofuran 
(THF) was prepared with the exclusion of moisture and stirred for 20 min under 
argon. Upon reaching room temperature both pyrrolidine (430 µL, 5.18 mmol) and 
benzaldehyde (480 µL, 4.71 mmol) were added in rapid succession and allowed to 
react over 24 h at ambient temperature. Upon completion (confirmed by GC-MS), the 
reaction mixture was poured into 400 mL of 1 M HCl solution and washed three times 
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with 75 mL of ethyl acetate. These organic portions were pooled and extracted three 
times with 1 M HCl and the HCl extractions were combined with aqueous phase. The 
combined aqueous phase was then basified with ammonium hydroxide (aqueous 
ammonium hydroxide can also be used as a base but caused more abundant 
precipitation of inorganic solids) and extracted three times with ethyl acetate (3 x 100 
mL). The pooled organic phases were washed with brine (10 mL), dried with 
anhydrous Na2SO4 and then the solvent was removed under reduced pressure to 
yield 820 mg crude material as a yellow oil. This material was purified via flash 
column chromatography utilizing silica gel as the stationary phase, and a mobile 
phase of ethyl acetate and hexanes (1:4) containing 1% triethylamine (TEA) to yield 
pure DPPy as a colorless oil (863 mg, 3.43 mmol, 73.2% yield calculated based on 
benzaldehyde). The purified material was converted into the HCl salt by titrating the 
free base with concentrated HCl solution in acetone until the pH < 2. The solvent was 
then evaporated under a stream of warm air several times to yield crystalline material 
in the absence of excess acid or moisture.  The solids were washed with diethyl 
ether (2 x 10 mL) in order to remove any color and any ether soluble impurities that 
may have formed during the salt formation process. After the washes with ether, the 
resulting crystals were dissolved in 15 mL of boiling acetone and 65 mL of diethyl 
ether added subsequently to crystallize the salt. The crystals yielded were collected 
by gravity filtration and washed with diethyl ether (2 x 30 mL), dried by gentle 
heating, and re-crystallized from acetone and diethyl ether (1:4) as described for a 
total of four times. The final solid material was then dried first in an oven (75 °C) 
followed by storage in a desiccator under vacuum to yield DPPy hydrochloride 
collected as a white crystalline powder (m.p. 216.0–217.0 °C, lit. 212 °C20). HR-
ASAP-MS observed at m/z 252.1752 (theory [M + H]+ C18H22N+, m/z 252.1747, Δ = 
1.98 ppm). 
Preparation of 1-[1-(2-fluorophenyl)-2-phenylethyl]pyrrolidine (2-F-DPPy) 
2-F-DPPy was prepared as described above using 2-fluorobenzaldehyde as the 
starting material to give pure 2-F-DPPy as a colorless oil (731 mg, 2.71 mmol, 67.3% 
yield). QTOF-MS m/z 270.16556 (theory [M + H]+ C18H21FN+, m/z 270.16525, Δ = 1.1 
ppm). The HCl salt was obtained as collected as colorless needles (m.p. 231.8–
232.5 °C).  
Preparation of 1-[1-(3-fluorophenyl)-2-phenylethyl]pyrrolidine (3-F-DPPy)  
3-F-DPPy was prepared as described above using 3-fluorobenzaldehyde as the 
starting material to give pure 3-F-DPPy as a colorless oil (747 mg, 2.77 mmol, 68.5% 
yield). QTOF-MS m/z 270.16576 (theory [M + H]+ C18H21FN+, m/z 270.16525, Δ = 1.9 
ppm). The HCl salt was collected as a white crystalline powder (m.p. 231.8–232.5 
°C).  
Preparation of 1-[1-(4-fluorophenyl)-2-phenylethyl]pyrrolidine (4-F-DPPy)  
4-F-DPPy was prepared as described above using 4-fluorobenzaldehyde as the 
starting material to give pure 4-F-DPPy as a colorless oil (452 mg, 1.68 mmol, 41.7% 
yield). QTOF-MS m/z 270.16598 (theory [M + H]+ C18H21FN+, m/z 270.16525, Δ = 2.7 
ppm).  The HCl salt was collected as colorless needles (m.p. 215.7–216.8 °C).  
Preparation of 1-[2-(2-fluorophenyl)-1-phenylethyl]pyrrolidine (2”-F-DPPy)  
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2”-F-DPPy was prepared as described above using 2-fluorobenzyl bromide as the 
starting material to give pure 2”-F-DPPy as a colorless oil (950 mg, 3.58 mmol, 
76.0% yield). QTOF-MS m/z 270.16593 (theory [M + H]+ C18H21FN+, m/z 270.16525, 
Δ = 2.5 ppm). The HCl salt was collected as a white crystalline powder (m.p. 195.7–
197.0 °C) 
Preparation of 1-[2-(3-fluorophenyl)-1-phenylethyl]pyrrolidine (3”-F-DPPy)  
3”-F-DPPy was prepared as described above using 3-fluorobenzyl bromide as the 
starting material to give pure 3”-F-DPPy as a colorless oil (721 mg, 2.68 mmol, 
56.8% yield). QTOF-MS m/z 270.16593 (theory [M + H]+ C18H21FN+, m/z 270.16525, 
Δ = 2.5 ppm). The HCl salt was collected as fluffy colorless needles (m.p. 215.4–
216.5°C) 
Preparation of 1-[2-(4-fluorophenyl)-1-phenylethyl]pyrrolidine (4”-F-DPPy)  
4”-F-DPPy was prepared as described above using 4-fluorobenzyl bromide as the 
starting material to give pure 4”-F-DPPy as a colorless oil (1003 mg, 3.88 mmol, 
79.0% yield). QTOF-MS m/z 270.16585 (theory [M + H]+ C18H21FN+, m/z 270.16525, 
Δ = 2.2 ppm). The HCl salt was collected as thick colorless chunky solids (m.p. 
207.2–209.0°C). 
2.3 Instrumentation 
2.3.1 Gas chromatography mass spectrometry  
For electron ionization mass spectrometry (EI-MS), a Finnigan TSQ 8000 Evo triple 
stage quadrupole mass spectrometer coupled to a gas chromatograph (Trace GC 
1310, Thermo Electron, Dreieich, Germany) and for chemical ionization (CI) MS a 
Finnigan TSQ 7000 triple stage quadrupole mass spectrometer coupled to a gas 
chromatograph (Trace GC Ultra, Thermo Electron, Dreieich, Germany) was used. A 
Triplus RSH (Thermo Scientific for TSQ 8000 Evo) and a CTC CombiPAL (CTC 
Analytics, Zwingen, Switzerland for TSQ 7000) autosampler was employed for 
sample introduction. Mass spectra were recorded at 70 eV electron ionization 
energy. The ion source temperature was set at 175°C and the emission current was 
50 µA (TSQ 8000 Evo) and 400 µA (TSQ 7000). For recording of EI-MS the scan 
time was 1 s spanning a scan range between m/z 29–m/z 600 and samples were 
injected in splitless mode.  
For CI, the reagent gas was methane and the source pressure was 1.5 mTorr (0.2 
Pa). The scan time was 0.5 s and the scan range was m/z 50–m/z 600 and samples 
were injected in splitless mode.  
In the CI-MS/MS-product-ion-mode, the ionization energy was 70 eV with an 
emission current of 400 µA and a source temperature of 175°C. The scan time was 1 
s and the scan range started at m/z 10 and ended about 10 mass units above the ion 
that was examined. The collision gas was argon. The collision energy was 
approximately 20 eV and the collision gas pressure was approximately 1.5 mTorr 
(0.2 Pa). The exact target-thickness was set using n-butylbenzene in EI-MS mode 
and adjusting intensity ratios m/z 92/91 to 0.2 and m/z 65/91 to 0.02 by variation of 
collision energy and collision gas pressure. This method ensured reproducibility of 
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the product ion mass spectra and the use of a product ion mass spectra library for 
the identification of the structures of the product ions.  
Separation was achieved using a fused silica capillary DB-1 column (30 m × 0.25 
mm, film thickness 0.25 µm). The temperature program consisted of an initial 
temperature of 80°C, held for 2 min, followed by a ramp to 280°C at 15 °C/min. The 
final temperature was held for 20 min. The injector temperature was 280°C (TSQ 
8000) and 220°C (TSQ 7000), respectively. The transfer line temperature was set at 
280 °C and the carrier gas was helium in constant flow mode at a flow rate of 1.0 
mL/min. Approximately 2 mg were dissolved in 2 mL of deionized  water, alkalized 
with a few drops of 5 % (w/v) NaOH  solution and extracted with  2 mL diethyl ether. 
For analysis, 1 µL of the extract was injected into the GC-MS system. Retention 
indices are given as Kovats indices calculated from measurement of a n-alkane 
mixture analyzed with the above mentioned temperature program. 
2.3.2 Gas chromatography solid-state infrared analysis 
Samples were analyzed using a GC-solid phase-IR-system that consisted of an 
Agilent GC 7890B (Waldbronn, Germany) with probe sampler Agilent G4567A and a 
DiscovIR-GC™ (Spectra Analysis, Marlborough, MA, USA). The column eluent was 
cryogenically accumulated on a spirally rotating ZnSe disk cooled by liquid nitrogen. 
IR spectra were recorded through the IR-transparent ZnSe disk using a nitrogen-
cooled MCT detector. GC parameters: injection in splitless mode with an injection 
port temperature set at 240°C and a DB-1 fused silica capillary column (30 m × 
0.32 mm i.d., 0.25 µm film thickness). The carrier gas was helium with a flow rate of 
2.5 mL/min and the oven temperature program was as follows: 80°C for 2 min, 
ramped to 290°C at 20 °C/min, and held at for 20 min. The transfer line was heated 
at 280°C. Infrared conditions: oven temperature, restrictor temperature, disc 
temperature, and Dewar cap temperatures were 280°C, 280°C, -40°C, and 35°C, 
respectively. The vacuum was 0.2 mTorr, disc speed 3 mm/s, spiral separation was 1 
mm, wavelength resolution 4 cm-1 and IR range 650–4000 cm-1. Acquisition time was 
0.6 s/file with 64 scans/spectrum. Data were processed using GRAMS/AI Ver. 9.1 
(Grams Spectroscopy Software Suite, Thermo Fisher Scientific, Dreieich, Germany) 
followed by implementation of the OMNIC Software, Ver. 7.4.127 (Thermo Electron 
Corporation, Dreieich, Germany). 
2.3.3 Infrared spectroscopy 
IR spectra were recorded on a Nicolet 380 FT-IR with a Smart Golden Gate Diamant 
ATR (Thermo Fisher Scientific). The wavelength resolution was 4 cm-1. IR spectra 
were collected in a range of 600–4000 cm-1 with 16 scans per spectrum. The IR data 
were processed using OMNIC Software, Ver. 7.4.127 (Thermo Electron Corporation). 
IR spectra of the free bases were recorded as neat film after the following sample 
preparation procedure: For the generation of the free bases, a few milligrams of the 
hydrochloride salts were dissolved in deionized water, alkalized with a few drops of 
aqueous NaOH solution (5% w/w) and extracted with diethyl ether. The organic 
phase was concentrated to approximately 100 µL by a gentle airflow, aspired with a 
glass pipette and transferred directly to the ATR crystal yielding a film of the free 
base after final evaporation of diethyl ether. 
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2.3.4 High mass accuracy electrospray ionization mass spectrometry  
Ultrahigh-performance liquid chromatography quadrupole time-of-flight single and 
tandem mass spectrometry (UHPLC-QTOF-MS/MS) data were obtained from an 
Agilent 6540 UHD Accurate-Mass QTOF LC-MS system coupled to an Agilent 1290 
Infinity UHPLC system (Agilent, Cheshire, UK). Separation was achieved using an 
Agilent Zorbax Eclipse Plus C18 column (100 mm × 2.1 mm, 1.8 µm) (Agilent, 
Cheadle, UK). Mobile phases consisted of acetonitrile (1% formic acid) and 1% 
formic acid in water. The column temperature was set at 40°C (0.6 mL/min) and data 
were acquired for 5.5 min. The gradient was set at 5–70% acetonitrile over 3.5 min, 
then increased to 95% acetonitrile in 1 min and held for 0.5 min before returning to 
5% acetonitrile in 0.5 min. QTOF-MS data were acquired in positive mode scanning 
from m/z 100–m/z 1000 with and without auto MS/MS fragmentation. Ionization was 
achieved with an Agilent JetStream electrospray source and infused internal 
reference masses. QTOF-MS parameters: gas temperature 325°C, drying gas 10 
L/min and sheath gas temperature 400°C. Internal reference ions at m/z 121.05087 
and m/z 922.00979 were used for calibration purposes.   
2.3.5 High performance liquid chromatography diode array detection 
HPLC-DAD analyses were carried out on an Agilent/Hewlett Packard (Little Island, 
Co. Cork, Ireland/Santa Clara, CA, USA) 1100 system (G1322A degasser, G1311A 
quaternary pump, G1313A autosampler and G1315A UV-visible diode array 
detector) using a Cosmosil πNAP column (4.6 mm x 150 mm, 5 µm)  (Nacalai 
Tesque, Inc., Kyoto, Japan). The injection volume, flow rate and ambient room 
temperature were 10 µL, 1.0 mL/min and 22°C, respectively. Mobile phase A 
consisted of 0.05 M ammonium formate (pH 10) and mobile phase B was 
acetonitrile. The gradient elution program was as follows. 0–1 min 50% A, 1–17 min 
down to 40% A, 17–18 min 40% A, 18–19 min up to 50% A, and 19–24 min 50% A. 
The diode array detection window was set at 200 nm to 400 nm (step, 2 nm). 
2.3.6 Nuclear magnetic resonance (NMR) spectroscopy 
1H (400 MHz) and 13C NMR spectra (101 MHz) were obtained from the hydrochloride 
salts (or in some cases freebases) in anhydrous d6-DMSO solutions (20 mg/mL) 
(>99.9% D, Sigma Aldrich) on a Bruker Ultrashield 400 plus spectrometer with a 5 
mm BBO S1 (Z gradient plus) probe at ambient temperature.  Internal chemical shift 
references were solvent (δ = 2.50 and 39.52 ppm for 1H and 13C spectra 
respectively). 19F (376.5 MHz) NMR was run as described using 
trichlorofluoromethane (99%+, Aldrich) as internal reference (δ = 0.0 ppm). NMR 
assignments were made using chemical shift position, splitting, 13C and 13C 
PENDANT and hetero- and homo- 2-D experiments such as HMQC, HMBC and 
COSY to confirm all assignments. A background water concentration of solvent 
(determined as integration ratio relative to solvent shift) was also determined in order 





3. Results and discussion 
 
Syntheses of the described 1,2-diarylethylamines were performed utilizing a 
convenient one-pot reaction referred to as the modified Mannich-Barbier reaction. 
This procedure was adapted from that employed by Le Gall et al. for the preparation 
of an assortment of arylakylamines.21 It is a three-component reaction involving a 
commercially available benzyl bromide, an aldehyde and an amine in the presence of 
zinc dust activated with trifluoroacetic acid (TFA). Both solvents acetonitrile and 
tetrahydrofuran (THF) gave good yields. The reaction can tolerate a very large scope 
of substitutions on both the benzyl bromide, aldehyde and amine. The reactions 
generally utilize convenient low cost reagents to produce final compounds in 
moderate to excellent yields. This method was utilized previously to prepare other 
1,2-diarylethylamines such as 2-MXP and 2-Cl-DPP 12,13 and a range of other 
diphenidine analogs.22 Finally, during final preparation of HCl salts, it was noticed via 
NMR that these crystals can form solvate co-crystals with methanol, ethanol, and 
isopropanol to differing degrees which led to the decision to employ acetone as the 
recrystallization solvent.  
3.1. Analytical features 
3.1.1 Mass spectrometry, chromatography and infrared spectroscopy 
The electron ionization (EI) mass spectra recorded for the two sets of three positional 
isomers are shown in Figure 2. As expected, each set of three isomers resulted in 
comparable mass spectra whereas significant differences could be found between 
the two sets of analogs substituted at the phenyl ring (2-F-, 3-F-, 4-F-DPPy) and 
those carrying the fluorine substituent at the benzyl moiety (2’’-F-, 3’’-F-, 4’’-F-DPPy). 
In the former case, the two most abundant fragments were observed at m/z 178 
(base peak), proposed to reflect α-cleavage and formation of an iminium ion and m/z 
109 that presumably represented the fluorinated tropylium species. Proposed 
fragmentation pathways using 4-F-DPPy as a representative example are depicted in 
Figure 3A. Correspondingly, the EI mass spectra of 2’’-F-, 3’’-F-, and 4’’-F-DPPy 
revealed the presence of m/z 160 and m/z 91 as a consequence of the fluorine 
substituent being located at the benzyl moiety instead (Figures 2 and 3B). From the 
perspective of EI-MS analysis, differentiation between the isomers was thus possible 
between the two groups that reflected the fluorine substituent at the two aromatic 
rings. In the cases of diphenidine and methoxyphenidine (Figure 1), the base peaks 
equivalent to the m/z 178 and/or m/z 160 ions detected here were recorded at m/z 
174 and m/z 204, reflecting the presence of the benzyl-piperidine and 
methoxybenzyl-piperidine moieties.11,12 Previous investigations on DPPy are thereby 
consistent with the nonfluorinated analogs of 2-F-, 3’’-F-, and 4’’-F-DPPy investigated 
in this study, which also gave rise to the base peak at m/z 160.11 A complete 
separation of all isomers using gas chromatography (GC) was unsuccessful under 
the conditions used, which was consistent with observations made during the 
investigation of three structurally related positional fluorinated isomers of 1-
cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45).23 
Implementation of GC chemical ionization mass spectrometry (CI-MS) confirmed the 
protonated molecules at m/z 270 and detection of adducts associated with the 
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reagent gas (methane) [M + 29]+ (m/z 298) and [M + 41]+ (m/z 310) of minor 
abundance. In single stage CI-MS mode, the protonated molecule experienced some 
fragmentation that resulted in the detection of additional ions including m/z 250 that 
was considered consistent with [M + H – HF]+ (Figure 4). Albeit at relatively low 
abundance, the m/z 72 ion, proposed to represent a pyrrolidin-1-ium species, could 
serve diagnostic purposes regarding the identity of the amine moiety. 
Correspondingly, diphenidine and methoxyphenidine (Figure 1) gave rise to m/z 
8611,12 whereas DPPy also yielded the m/z 72 ion.11 Figure 5A depicts a proposed 
fragmentation pathway using 4-F-DPPy as a representative example. Similar to what 
was observed under EI-MS conditions, both sets of isomers yielded distinctive base 
peaks at m/z 178 and m/z 160 when subjected to analysis by CI-MS, possibly as a 
consequence of losing either toluene (Figure 5A) or fluorinated toluene, respectively 
(Figure 5B).  
The formation of [M + H – HF]+ under CI-MS conditions at m/z 250 prompted further 
investigations by employing additional GC-CI-QqQ-MS/MS experiments, which was 
found to be particularly helpful as this enabled differentiation between all six isomers 
(Figure 6). 2-F-DPPy generated the most extensive number of product ions where 
abundant ions detections included m/z 70, 103, 131, 158, 159, 166, 179, and m/z 
181 (base peak). Key ions recorded for 3-F-DPPy included m/z 91, 159, 174 (base 
peak), and m/z 179. In case of 4-F-DPPy, the [M + H – HF]+ ion maintained highest 
stability (base peak) but less abundant ions were detected including m/z 91, 159, and 
m/z 181 (Figure 6). The CI tandem mass spectra collected for the second set of 
isomers substituted at the benzyl group differed both in all three cases but also from 
fluorolintane (2-F-DPPy) and its two fluorophenyl positional isomers. Interestingly, 
the [M + H – HF]+ ion at m/z 250 remained most stable in the mass spectrum derived 
from 2’’-F-DPPy whereas it was absent in the spectrum of 3’‘-F-DPPy, which was 
dominated by the base peak at m/z 160. In comparison, the base peak detected for 
4’‘-F-DPPY was detected at m/z 158 together with a number of product ions of low to 
moderate abundance including m/z 130, 144, 166, 173, and m/z 181, respectively 
(Figure 6). The combination of using chemical ionization with tandem mass spectra 
analysis of the [M + H – HF]+ ion has been previously reported to also facilitate the 
differentiation between various fluorinated amphetamine and cathinone isomers.24,25 
A suggested fragmentation scheme, using 2-F-DPPy and 4’‘-F-DPPY as 
representative examples, is presented in Figure 7.  
UHPLC-ESI-QTOF-MS/MS analysis results are presented in Figure 8, which 
indicated that both chromatographic and mass spectrometric information were 
insufficient to facilitate a differentiation between the isomers. Main ions included m/z 
72, 103, 121, 159, 179 and m/z 199 (base peak). Implementing the high mass 
accuracy option supported the formulation of proposed dissociation pathways 
suggested in Figure 9. The base peak at m/z 199 was thought to arise from  loss of 
pyrrolidine from the protonated molecule. To some extent, this loss was also 
observable under CI-MS conditions although the abundance of m/z 199 was 
comparatively low to moderate in comparison. The equivalent species of m/z 199 
reported for diphenidine, methoxdiphenidine, and DPPy following ESI-QqQ-MS/MS 
analysis were m/z 166, m/z 211, and m/z 166.11,12 Similar to what was observed 
under CI-MS conditions, the detection of m/z 72 was diagnostic for the pyrrolidine 
component (C4H10N+).  
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As far as HPLC-based analyses were concerned, initial attempts to achieve 
adequate separations with various standard C18 columns proved unsuccessful but 
then it was hypothesized that an increase in π-π interactions between column 
stationary phase and analytes (under alkaline conditions) might be beneficial. As 
depicted in Figure 10, adequate separations of isomers were obtained when 
employing a stationary phase containing naphthalene bonded silica packing material 
(Cosmosil πNAP column). However, the separation of all six isomers was not 
successful within the same chromatographic run. The implementation of a Hypersil 
GOLD™ PFP column was reported to facilitate the separation of three fluorinated 
amphetamine and methamphetamine isomers.26 As expected, inspection of all UV 
full scan spectra recorded from HPLC-DAD analysis revealed that no specific 
differences between the six isomeric compounds could be identified (supporting 
information).   
The implementation of GC condensed phase IR analysis (GC-sIR) allows for the 
collection of spectral data directly from chromatographic peaks whereby the analyte 
is deposited cryogenically onto an IR-transparent zinc selenide disk. The advantage 
of employing this method is that IR spectra are recorded in a solid state comparable 
to freebase spectra recorded under traditional conditions; for example, by using a 
Fourier transform attenuated total reflection (ATR) approach. Figures 11 and 12 
show a partial section of the IR spectrum for the purpose of comparison. A direct 
comparison indicated that the three isomers within each group (2-F-, 3-F-, 4-F- and 
2’’-F-, 3’‘-F-, 4’‘-F-DPPy) yielded distinctive IR spectra. IR spectra collected over the 
full scan range (as HCl salts, freebase and GC-sIR) are provided as Supporting 
Information. For example, the IR spectra of 4-F-DPPy and 4’’-F-DPPy contained 
sharp intense band at 1220 cm-1 and, in particular, at 1510 cm-1, which distinguish 
this isomer form the two other isomeric sets. A comparison of 2-F/2’’-F-, 3-F/3’‘-F-, 
and 4-F/4’‘-F-DPPy also indicated that differences identified in the IR spectra were 
still observable (Figures 11 and 12) (supporting information).  
 
3.1.2 Nuclear magnetic resonance spectroscopy (NMR) 
3.1.2.1 Aliphatic 1H chemical shifts 
The aliphatic 1H spectra measured with the current series were consistent with those 
reported previously for diphenidine and several related 1,2-diarylethylamines (Tables 
1 and 2).11,12 In order to determine the effect of fluorine substitution on chemical shift 
behavior, DPPy was also evaluated. 1H chemical shift assignments for the HCl salts 
of DPPy, fluorolintane and its 5 positional fluorine-isomers are presented in Tables 1 
and 2. In addition, the freebase spectra and assignments for fluorolintane are 
provided as Supporting Information.   
In all compounds, the assigned H1 shift was always shifted downfield relative to H2, 
with the latter giving separate multiplets (each integrating to 1 proton) for both 
protons. The substitution with fluorine in the phenyl-substituted series (i.e., 2-, 3-, 4-F 
series) in 2-F-DPPy, led to a further downfield shift of H1 relative to DPPy, and 
compared to the corresponding C1’’ benzyl-substituted (i.e., 2’’-, 3’-’, 4‘’-F isomers). 
This shift was most dramatic in the case of 2-F-DPPy (~0.3 ppm) likely due to the 
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closer proximity of the fluorine substitution causing an inductive deshielding effect, 
followed by 3-F-DPPy with only a modest effect (0.05 ppm). Supporting this, no 
comparable fluorine effect on the H2 1H chemical shift was observed with the phenyl-
substituted series. A comparable effect was observed with 2’’-F-DPPy (but not other 
benzyl series isomers), however in which one of the two 1H chemical shifts assigned 
to H2 (the more upfield shift) was shifted (0.13 ppm) downfield relative to DPPy. 
Again, the relative downfield shift for the H2 1H chemical shift for 2’’-F-DPPy, was 
likely the result of inductive deshielding effects. This downfield shift is thus potentially 
of analytical value for distinguishing the 2-F-DPPy and 2’’-F-DPPy isomers using the 
1H spectra.  
The 1H chemical shifts assigned to Hα of the pyrrolidine ring appeared as up to four 
separate multiplets. Whereas four separate multiplets were observed in most cases, 
in a few cases (such as the upfield shifts of 2’’-F and 4’’-F), the upfield multiplet 
coalesced and the resulting broad multiplets integrated to two protons. The Hβ 1H 
chemical shifts were also complex and appeared either as a single broad multiplet as 
in 2-F-DPPy or in all other cases as three separate multiplets, in which the most 
downfield multiplet integrated to two protons. 
It is worth noting that in the corresponding 13C spectra, the Cα and Cβ 13C shifts 
appeared as two distinct 13C chemical shifts, with each 13C shift showing cross 
correlation with one or more 1H multiplets (integrating for a total of 2 protons) in the 
HMQC spectra. In these 2-dimensional spectra, the upfield 13C shift always 
correlated with the two most upfield proton shift(s) and vice versa for the downfield 
shifts.  
These magnetic nonequivalence patterns for Cα and Cβ shifts observed in the 1H and 
13C spectra, are likely the result of amine nitrogen protonation inducing a distinct 
conformational state of the pyrrolidine ring, which led to asymmetry in the electronic 
environments experienced by the otherwise symmetric protons causing magnetic 
nonequivalence under the experimental conditions. This nonequivalence is 
supported by the fact that in the case of fluorolintane freebase (supporting 
information) the 1H chemical shifts assigned to Hα appeared as two multiplets 
(integrating to two each and thus representing axial and equatorial protons) and the 
corresponding 13C shifts for Cα and Cβ each appeared as a single chemical shift. This 
phenomenon has been observed previously with diphenidine and related 
compounds.11,12 
3.1.2.2 Aromatic 1H chemical shifts 
The 1H chemical shifts belonging to the aromatic protons behaved as expected for 
fluorine-substituted aromatic rings.27 Notably, the 1H chemical shift assigned to 
proton(s) ortho- to the fluorine substitution were shifted upfield relative to the 
corresponding 1H chemical shifts in DPPy for all six fluorine-substituted isomers. For 
example, in fluorolintane, the 1H shift assigned to H3’ was shifted ~0.25 ppm upfield 
relative to the corresponding H3’ shift of DPPy. A comparable effect was seen with 
respect to protons on the position of the ring para- to fluorine. For example, in the 
case of 3-F-DPPy, the assigned H6’ was 0.25 ppm upfield relative to the 
corresponding shift in DPPy. The upfield shifts were attributed to the resonance 
donating effects of fluorine.27 As expected, the 1H chemical shifts assigned to protons 
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meta- to the fluorine substitution were shifted downfield relative to DPPy for all six 
isomers, though in some cases the effect was only modest. For example, the 1H 
chemical shift for 4-F-DPPy assigned to H2’,6’ (meta to 4-F) was 0.1 ppm downfield 
relative to DPPy. In addition, the different meta-protons on the same compound were 
affected to a different extent, as can be seen with fluorolintane, where a shift of 0.6 
ppm was observed for H6’ but there was no comparable effect on H4’ (relative to 
corresponding shifts in DPPy).This difference may be due to additional effects from 
the alkyl substitution on the ring. The corresponding downfield shifts for protons 
attached to carbons meta- to the fluorine substituted carbon were consistent with the 
inductive withdrawing effect of fluorine that is most apparent on the relative meta- 
positions of the aromatic ring, which do not experience resonance donating effects.27  
 
3.1.2.3 13C chemical shifts 
The 13C chemical shift assignments for DPPy, fluorolintane and its 5 positional 
isomers are presented in Table 3 and refer to the hydrochloride salts. The C1 13C 
chemical shift for 2-F-DPPy was ~8 and ~7 ppm upfield relative to the corresponding 
shift of DPPy and 3-F- and 4-F-DPPy isomers respectively. Interestingly, a similar 
upfield shift for C2 was observed for 2’’-F-DPPy of ~7 and 6 ppm for DPPy and 3’’-F- 
and 4’’-F-DPPy isomers, respectively. As stated previously, Cα and Cβ each gave two 
13C chemical shifts, which correlated to two protons each in the HMQC spectra.   
Fluorine substitution led to a large downfield shift relative to DPPy for all fluorine 
isomers, with the ipso-carbon shifts appearing around 160 ppm. 13C shifts assigned 
to carbons ortho- to the CF carbon were shifted upfield relative to the corresponding 
shift in DPPy. For example, for fluorolintane, C1’ and C3’ shifts were shifted ~12.5 
ppm upfield relative to DPPy and similar shifts were seen for the other five isomers. 
In the case of carbons meta- to fluorine, there was a slight downfield shift (~3 ppm). 
Para- 13C chemical shifts exhibited an upfield shift (~3 ppm) relative to DPPy. Again, 
the upfield shifts seen with ortho- and para-positons relative to the CF carbon were 
expected and consistent with the resonance-donating effects of fluorine. Likewise, 
the downfield shift seen with carbons meta- to the fluorine substation were consistent 
with the inductive withdrawing effect of fluorine.27 As described above, a comparable 
effect was observed in the corresponding 1H spectra. HMBC was particularly helpful 
in distinguishing benzyl and phenyl fluorine series due to the expected correlations 
occurring between the C1 positions (C1’ and C1’’) of the aromatic rings and the C1 and 
C2 ethyl chain proton shifts.  
3.1.2.4 Fluorine splitting of 13C chemical shifts and 19F NMR 
Fluorine substitution is known to split 13C chemical shifts belonging to ipso- and 
adjacent carbons (3-4 bonds) due to coupling between 19F-and 13C nuclei. In the 
present experiments, these splits were observed for all six F-DPPy isomers. The J-
values were found to be greatest for C-ipso (246 Hz), ortho- to the CF carbon (0-
~22.2 Hz), followed by meta- (~0-8.1 Hz) and lastly para- (0-3 Hz). These coupling 
constants were consistent with those expected based on studies with fluorobenzene 
and related compounds.27 This feature can help with assignments of 13C chemical 
shifts on fluorinated aromatic rings.19F chemical shifts for the six F-DPPy isomers is 
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presented in Table 4. Chemical shifts ranged from -111.58 to -117.10. The rank order 
from most downfield to most upfield was observed as follows: 3-F > 3’’-F > 4-F > 4’’-F 
> 2-F > 2’’-F. 
4. Conclusion 
Fluorolintane (1-[1-(2-fluorophenyl)-2-phenylethyl]pyrrolidine, 2-F-DPPy) is a new 
psychoactive substance that belongs to the 1,2-diarylethylamine class and it appears 
that it might exert dissociative effects in humans. The presence of the fluorine 
substituent on either the phenyl and benzyl moieties gives rise to a total number of 
six possible racemic isomers, namely 2-F-, 3-F-, and 4-F-DPPy (phenyl) and 2’’-F-, 
3’’-F-, and 4’’-F-DPPy (benzyl), which adds to the analytical challenges that might be 
encountered in forensic investigations and/or toxicological casework. The isomers 
could be differentiated by NMR but subjecting the substances to chemical ionization 
triple quadrupole tandem mass spectrometric analysis was considered particularly 
useful when it transpired that the product ion mass spectra derived from the [M + H – 
HF]+ species facilitated the differentiation between all six racemic isomers. GC-MS 
analyses were unable to result in complete differentiation whereas analysis by HPLC 
provided adequate separation between 2-F-, 3-F-, and 4-F-DPPy and 2’’-F-, 3’’-F-, 
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Figure 1. 1,2-Diarylethylamines and related arylcyclohexylamines including 
phencyclidine (PCP) and ketamine. The numbering scheme is used for NMR 
assignments. The naming of fluorolintane isomers (2-F-, 3-F-, and 4-F-DPPy) was 
based on historical reasons where the first phenyl ring has been used without a 
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Figure 3. A. Proposed fragmentation pathways of 4-F-DPPy under electron 
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Figure 4. Gas chromatography chemical ionization mass spectra of the two sets of 
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Figure 5. A. Proposed fragmentation pathways of 4-F-DPPy under chemical 
ionization tandem mass spectrometry conditions. B. Proposed fragmentation 
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Figure 6. Gas chromatography product ion mass spectra of the [M + H – HF]+ 

































































































































Figure 7. Proposed chemical ionization tandem mass spectral fragmentation 
pathways originating from the [M + H – HF]+ ion using 2-F-DPPy (fluorolintane) and 
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Figure 9. A. Proposed collision-induced dissociation pathways of 4-F-DPPy under 
quadrupole time-of-flight tandem mass spectrometry conditions. Proposed 
fragmentation pathways of 4”-F-DPPy. 
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Δ = 3.85 ppm 
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Figure 10. High performance liquid chromatography ultraviolet analysis of all 
positional isomers using a Cosmosil πNAP column. 
 
 



















































































































































































































































































































































































































































































































































































































































Table 1. 400 MHz 1H NMR of HCl salts. Twenty mg/mL in DMSO-d6. Shifts in ppm and set to solvent 
reference (2.50 ppm).  
1H [δ / 
ppm] 
DPPy 2-F-DPPy 3-F-DPPy 4-F-DPPy 
H1 4.60 (ddd, J = 
12.1, 8.3, 4.1 Hz, 
1H) 
4.90 (ddd, J = 11.9, 
8.1, 4.3 Hz, 1H) 
4.65 (ddd, J = 11.9, 
8.1, 4.2 Hz, 1H) 
4.62 (ddd, J = 11.9, 8.5, 
4.2 Hz, 1H) 
H2 3.62 (dd, J = 13.2, 
4.1 Hz, 1H) 
 
3.32 (t, J = 12.3 
Hz, 1H)  
*overlap with Hα 
3.64 (dd, J = 13.0, 
4.2 Hz, 1H) 
3.30 (t, J = 12.4 Hz, 
1H) 
3.62 (dd, J = 13.2, 
4.2 Hz, 1H) 
3.34 – 3.21 (m, 1H) 
*overlap with Hα 
3.61 (dd, J = 13.2, 4.1 
Hz, 1H) 
3.28* (t, J = 12.5 Hz, 
1H)  
*overlap with Hα 
Hα 3.81 (ddd, J = 
11.5, 6.6, 5.8 Hz, 
1H) 
3.37–3.25 (m 1H) 
*overlap with H2 
2.94–2.85 (m, 1H) 
2.83 (ddd, J = 
15.5, 11.0, 8.5 Hz, 
1H) 
3.90-3.79 (m, 1H) 
3.50–3.41 (m, 1H) 
3.02 (s, 1H) 
2.82–2.71 (ddd, J = 
15.6, 8.4, 11.1 Hz, 
1H) 
3.88-3.77 (m, 1H) 
3.34–3.21 (m, 1H) 
*Overlap with H2 
3.0–2.90 (m, 1H) 
2.90–2.77 (ddd, J = 
15.5, 11.1, 8.3 Hz, 
1H) 
3.89-3.74 (m, 1H) 
3.34–3.22 (m, 1H) 
*overlap with H2 
2.99–2.86 (m, 1H) 
2.86–2.72 (ddd, J = 
15.5, 11.2, 8.5 Hz 1H) 
Hβ 2.10–1.92 (m, 2H) 
1.92–1.74 (m, 2H) 
2.10–1.79 (m, 4H) 2.09–1.95 (m, 2H) 
1.95–1.87 (m, 1H) 
1.86–1.74 (m, 1H) 
2.00 (q, J = 8.2, 7.5 Hz, 
2H) 
1.90 (d, J = 8.9 Hz, 1H) 
1.85–1.72 (m, 1H) 
H2’ 7.65–7.47 (m, 2H) – 7.51 (dm, J = 10.2 
Hz, 1H) 
 
7.70–7.49 (m, 1H) 
H3’ 7.40–7.25 (m, 2H) 
*overlap with H4’ 
7.12–7.03 (m, 1H) 
*overlap with H4’’ 
– 7.21–7.16 (m, 1H) 
*overlap with H3’’,5’’ 
H4’ 7.40–7.25 (m, 1H) 
*overlap with H3’,5’ 
7.40–7.33 (m, 1H) 7.15–7.13 (m, 1H) – 
H5’ 7.40–7.25 (m, 2H) 
*overlap with H4’ 
7.29 (td, J = 7.5, 
1.3 Hz, 1H) 
7.35 (td, J = 7.9, 
5.9 Hz, 1H) 
 
7.21–7.16 (m, 1H) 
*overlap with H3’’,5’’ 
H6’ 7.65–7.47 (m, 2H) 8.14 (t, J = 7.4 Hz, 
1H) 
7.30 (dt, J = 7.7, 
1.4 Hz, 1H) 
7.70–7.49 (m, 1H) 
H2’’ 6.98 (dm, J = 8.3 
Hz, 2H) 
7.03–6.97 (m, 1H), 7.04–6.97 (m, 1H) 6.99 (dm, J = 8.3 Hz, 
1H) 
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H3’’ 7.12 (dm, J = 7.4 
Hz, 2H)*overlap 
with H4’’ 
7.18–7.12 (m, 1H) 7.20–7.15 (m, 1H) 7.14 (dm, J = 7.4 Hz, 
1H) 
*overlap with H3’,5’ and 
H4’’ 




7.12–7.03 (m, 1H) 
*overlap with H3’ 
7.13–7.07 (m, 1H) 7.11–7.08 (m, 1H) 
*overlap with H3’’,5’’ 
H5’’ 7.12 (dm, J = 7.4 
Hz, 2H) 
*overlap with H4’’ 
7.18–7.12 (m, 1H) 7.20–7.15 (m, 1H) 7.14 (dm, J = 7.4 Hz, 
1H) 
*overlap with H3’,5’ and 
H4’’ 
H6’’ 6.98 (dm, J = 6.9 
Hz, 2H) 
7.03–6.97 (m, 1H), 7.04–6.97 (m, 1H) 6.99 (dm, J = 8.3 Hz, 
1H) 
NH+ 11.98 (s, 1H) 11.82 (s, 1H) 11.84 (s, 1H) 11.74 (s, 1H) 
	
Table 2. 400 MHz 1H NMR of HCl salts. Twenty mg/mL in DMSO-d6. Shifts in ppm set to 
solvent reference (2.50 ppm). 
1H [δ / ppm] 2’’-F-DPPy 3’’-F-DPPy 4’’-F-DPPy 
H1 4.58 (ddd, J = 12.3, 
8.6, 4.3 Hz, 1H) 
4.61 (ddd, J = 12.1, 
8.2, 4.1 Hz, 1H) 
4.56 (ddd, J = 11.8, 7.7, 3.9 
Hz, 1H) 
H2 3.59 (dd, J = 13.4, 
4.2 Hz, 1H) 
3.43 (t, J = 12.6 Hz, 
1H) 
3.64 (dd, J = 13.2, 4.0 
Hz, 1H) 
3.36–3.27 (m, 1H) 
*Overlap with Hα  
3.60 (dd, J = 13.2, 4.1 Hz, 
1H) 
3.34–3.24 (m, 1H)  
*Overlap with Hα 
Hα 3.98–3.80 (m, 1H)  
3.33–3.18 (m, 1H) 
2.96–2.72 (m, 2H) 
3.85–3.75 (m, 1H) 
3.36–3.27 (m, 1H) 
*Overlap with H2 
2.90–2.85 (m, 1H) 
2.79 (dq, J = 10.0, 8.3 
Hz, 1H)  
3.85–3.76 (m, 1H) 
3.34–3.24 (m, 1H  
*Overlap with H2 
2.93–2.85 (m, 1H) 
2.79 (dq, J = 10.2, 8.4 Hz, 
1H) 
Hβ 2.08–1.95 (m, 2H) 
1.95–1.85 (m, 1H) 
1.85–1.73 (m, 1H) 
2.06–1.95 (m, 2H) 
1.94–1.86 (m, 1H) 
1.86–1.73 (m, 1H) 
2.10–1.95 (m, 2H)  
1.94–1.85 (m, 1H) 
1.86–1.75 (m, 1H) 
H2’ 7.54 (dd, J = 6.7, 2.9 
Hz, 2H) 
7.57–7.50 (m, 2H) 7.53–7.50 (m, 2H) 
H3’ 7.36–7.25 (m, 2H) 
*overlap with H4’ 
7.37–7.28 (m, 2H) 
*overlap with H4’’ 
7.36–7.28 (m, 2H)  
*overlap with H4’’ 
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H4’ 7.36–7.25 (m, 1H) 
*overlap with H3’,5’ 
7.37–7.28 (m, 1H) 
*overlap with H3,5’’ 
7.36–7.28 (m, 1H)  
*overlap with H3,5’’ 
H5’ 7.36–7.25 (m, 2H) 
*overlap with H4’ 
7.37–7.28 (m, 2H) 
*overlap with H4’’ 
7.36–7.28 (m, 2H) 
H6’ 7.54 (dd, J = 6.7, 2.9 
Hz, 2H) 
7.57–7.50 (m, 2H) 7.53–7.50 (m, 2H) 
H2’’ – 6.95–6.86 (m, 1H) 
*Overlap with H4’’ 
7.02–7.00 (m, 2H) 
H3’’ 7.08–7.0 (m, 1H) 
*overlap with H6’’ 
– 6.97–6.95 (m, 2H) 
H4’’ 7.20–7.11 (m, 1H)  6.95–6.86 (m, 1H) 
*overlap with H2’’ 
– 
H5’’ 6.96 (td, J = 7.6, 1.1 
Hz, 1H) 
7.16 (td, J = 7.9, 6.2 
Hz, 1H) 
6.97–6.95 (m, 2H) 
H6’’ 7.07–7.0 (m, 1H) 
*overlap with H3’’ 
6.80 (dt, J = 7.7, 1.2 
Hz, 1H) 
 
7.02–7.00 (m, 2H) 
NH+ 11.90 (s, 1H) 11.67 (s, 1H) 11.72 (s, 1H) 
	
Table 3. 101 MHz 13C NMR of HCl salts. Twenty mg/mL in DMSO-d6. Shifts in ppm, and set to 
solvent reference (39.52 ppm). 





















C1 69.67 61.73 68.97 68.76 68.56 69.28 69.68 

































131.35 134.84 134.79 134.90 








128.80 129.05 129.04 
C3’ 128.60 115.59 163.14 115.65 128.61 128.74 128.70 
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115.37 160.71 115.44 








129.11 129.15 129.06 






128.61 128.74 128.70 




128.80 129.05 129.04 





































Table 4. 376.5 MHz 19F NMR of HCl salts. Twenty 
mg/mL in DMSO-d6. Reference CFCl3 (0.00 ppm). 
Compound 19F NMR 
2-F-DPPy -116.29 
3-F-DPPy -111.58 
4-F-DPPy -112.05 
2’’-F-DPPy -117.10 
3’’-F-DPPy -113.08 
4’’-F-DPPy -115.79 
 
 
